Frequently Asked Questions

Conference Speakers

Cultural Speakers

Cultural practices, beliefs, and norms play a very important role not only in delivering health care to clients and patients, but also in how that health care is received and what outcomes are possible. Diversity within those beliefs and practices, and as a result of available resources or social economic/demographic circumstances, must be fully understood in order for health care professionals to provide the best care possible no matter where they are in the world, or what culture they are practicing within.

At GOLD Perinatal Care, we understand the importance of Culture and Diversity in health care, and we are working hard to bring you speakers and presentations from around the world that will help you understand the patients and clients you are working with. Discovering how health care is provided and received in other countries and cultures around the world can have a positive impact on our own professional practice. Given that culture is defined by much more than political borders, GOLD Perinatal Care invites speakers to share their knowledge and expertise about perinatal health care from a geographically-based focus or a people-group focus from within a particular set of beliefs, lifestyle or minority. This year, our Culture and Diversity speakers will be presenting on:

- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Dr. Second Speaker Name
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
View Registration Info
Speakers

Speakers (5191)

Sunday, 08 August 2021 11:18

Ming Sound Tsao

Written by
Sunday, 08 August 2021 11:18

Leung Chu B Tong

Written by
Sunday, 08 August 2021 11:18

Scott L Boerner

Written by
Sunday, 08 August 2021 11:18

Heather M Ruff

Written by
Sunday, 08 August 2021 11:18

Sharon Nirmalakumar

Written by
Sunday, 08 August 2021 11:18

Jessica Weiss

Written by
Sunday, 08 August 2021 11:18

Sally CM Lau

Written by
Sunday, 08 August 2021 11:18

Lukas Bubendorf

Written by
Prof. Lukas Bubendorf is a surgical pathologist and head of cytopathology at the Institute for Pathology of the University Hospital Basel, Switzerland. He completed a post-doctoral research fellowship at the National Human Genome Research Institutes at the NIH, Bethesda, from 1998-2000.
He is a member of numerous national and international scientific societies, the Steering Committee of the ETOP Lungscape project, the IASLC Pathology Committee and the editorial boards of several journals including Journal of Thoracic Oncology, JTO Clinical and Research Reports, Lung Cancer, Pathobiology, Journal of Molecular Pathology, Cancer Cytopathology, Diagnostic Cytopathology, and Acta Cytologica.
Professor Bubendorf is the author of more than 300 papers in peer-reviewed journals and several book chapters. His major interests and diagnostic expertise lie within thoracic pathology and uropathology, and in the general field of cytopathology. His research group currently investigates the role of plasticity, genomic evolution and heterogeneity in solid tumors, including lung cancer. He also aims at translating molecular techniques and assays to clinical routine application.
Sunday, 08 August 2021 11:18

Umberto Mallapelle

Written by
Assistant Professor in Anatomic Pathology in School of Medicine, University of Naples Federico II.
Currently is the Chief Supervisor of Predictive Molecular Pathology Laboratory, Department of Public Health of University Federico II of Naples.
His main research interest is in the field of genomic biomarkers validation and testing for predictive information in the field of lung cancer, metastatic colorectal cancer, melanoma and gastrointestinal stromal tumor.
Moreover, he has developed skills in tailoring Next Generation Assays for a number of different applications with a special focus on the simultaneously detection of clinical relevant alterations (i.e., EGFR mutations, ALK traslocation, PD–L1 expression) in the routine setting including handling of different sample types, such as tissues and/or liquid biopsy specimens.
Page 225 of 371